Elranatamab

ATC L01FX32 · 10 markets · 20 records

Elranatamab 10 markets · 20 records Forms

AU 5 records · 5 strengths

  • 76 mg/1.9 mLinjectionElrexfio also in US·GB·SG
  • 44 mg/1.1 mLinjectionElrexfio also in US·GB·SG
  • 76 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial unknown
  • 44 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 3 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 1 strengths

SG 2 records · 2 strengths

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML ×8

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    ES 1 records · 1 strengths

    TW 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      FR 1 records · 1 strengths

      • 40 mg/1 mLinjectionELREXFIO 40 mg/mL, solution injectable also in ES

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.